This molecule is a NOX1/4 inhibitor developed to prevent oxidative stress and fibrosis in multiple diseases including primary idiopathic fibrosis, primary biliary cholangitis, and diabetic nephropathy [67]. Here, NOX1 is linked to primary biliary cholangitis.